Tag: Pediatric Endocrinology
-
Diabetes in Children: Insights from Dr. Olowaro Olopade, Lagos’ Endocrinologist
Childhood Diabetes Isn’t Bound by Age Diabetes can affect anyone, including newborns and very young children. In Nigeria, specialists like Dr. Oluwarotimi Bolaji Olopade, a physician and endocrinologist at Lagos University Teaching Hospital (LUTH), emphasize that diabetes does not discriminate by age. Through his work with the Endocrine and Metabolism Society of Nigeria (EMSON) and…
-
Type 2 Diabetes Among Youth Rising: Doctors Sound Alarm Ahead of World Diabetes Day
Worldwide Warning: More Young People Diagnosed with Type 2 Diabetes In what experts describe as a worrying shift, doctors report a sharp rise in Type 2 diabetes among children and young adults. Previously considered a condition mostly affecting adults, Type 2 diabetes is now increasingly diagnosed in younger populations, prompting urgent calls for heightened awareness,…
-
Rising Type 2 Diabetes in Ghanaian Children: A Wake-Up Call for Health Systems
Overview: A worrying trend in pediatric health Health experts in Ghana are sounding the alarm on rising cases of type 2 diabetes among children and adolescents. The concern comes from the Diabetes, Endocrine and Metabolic Society of Ghana, which has highlighted the shift in the country’s disease landscape from predominantly infectious diseases to chronic conditions…
-
Steroid Weaning in Children Reduces Adrenal Crisis
Why steroid tapering matters in pediatric care High-dose glucocorticoids are a common part of treating chronic pediatric conditions such as nephrotic syndrome and juvenile idiopathic arthritis (JIA). While effective for disease control, these therapies carry a risk of adrenal suppression if they are stopped abruptly or tapered too quickly. A recent single-center retrospective study conducted…
-
Canada Welcomes Sogroya: The First Weekly Growth Hormone Therapy for GHD
Canada Launches Sogroya as the First Weekly Growth Hormone Therapy for GHD Canada has welcomed Sogroya® (somapacitan injection) as a new, once-weekly option for children and adults living with growth hormone deficiency (GHD). This landmark approval marks the first and only regimen of its kind that reduces the frequency of injections while delivering effective growth…